Literature DB >> 22437135

Robotic-assisted excision of a left ventricular thrombus.

Charles J Lutz1, Castigliano M Bhamidipati, Brant Ford, Mike Swartz, Michael Hauser, Moses Kyobe, Karikehalli Dilip.   

Abstract

OBJECTIVE: : Left ventricular thrombus is a rare entity usually associated with myocardial infarction. The daVinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, Calif) offers excellent visualization of the mitral subvalvular apparatus and should provide an effective means to excise a left ventricular mass.
METHODS: : A 34-year-old man presented to an outside institution with fever of unknown origin and ulcerative colitis. As part of this workup, he underwent a transthoracic echocardiogram and subsequently a transesophageal echocardiogram that showed a 2-cm left ventricular apical pedunculated mass. He was referred to our institution for excision of this ventricular mass. Because of the pedunculated nature of the mass, he was deemed a candidate for a robotic-assisted minimally invasive approach.
RESULTS: : The patient underwent successful robotic-assisted excision of a left ventricular mass. Total robotic time was 15 minutes. Pathology revealed that the mass was a left ventricular thrombus. The patient experienced an uneventful recovery and was discharged home in 4 days.
CONCLUSIONS: : Left ventricular mass excision can be safely performed with the daVinci Surgical System. The daVinci Surgical System offers excellent visualization of the entire left ventricular cavity.

Entities:  

Year:  2007        PMID: 22437135     DOI: 10.1097/IMI.0b013e31815cea73

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  2 in total

1.  Robotic assisted excision of a left ventricular myxoma.

Authors:  Mohammed Hassan; J Michael Smith
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-15

2.  Surgical removal of a large mobile left ventricular thrombus via left atriotomy.

Authors:  Daizo Tanaka; Shinya Unai; James T Diehl; Hitoshi Hirose
Journal:  World J Clin Cases       Date:  2014-02-16       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.